Director, Settlement Clinic
Professor and Chair, Department of Pharmaceutical Sciences
University of South Florida, USA
Department of Biomolecular Sciences
University Carlo Bo of Urbino, Italy
Submit manuscript at www.walshmedicalmedia.com/submissions/pharmacogenomics-pharmacoproteomics.html or send as an e-mail attachment to the Editorial Office at [email protected]
NLM ID: 101575137
Index Copernicus Value 79.65
The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.
The Pharmacogenomics & Pharmacoproteomics Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members Pharmacogenomics & Pharmacoproteomics journal impact factor is mainly calculated based on the number of articles that undergo a single blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacogenomics and Pharmacoproteomics Open Access Journals are freely accessible to everyone immediately after publication.
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Pharmacogenomics & Pharmacoproteomics is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12 , which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.